BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32804798)

  • 1. Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort.
    Mezochow AK; Abt PL; Bittermann T
    Transplantation; 2021 Aug; 105(8):1800-1807. PubMed ID: 32804798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
    World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolution of Redo Liver Transplantation Over 35 Years: Analysis of 654 Consecutive Adult Liver Retransplants at a Single Center.
    Kaldas FM; Horwitz JK; Noguchi D; Korayem IM; Markovic D; Ebaid S; Agopian VG; Yersiz H; Saab S; Han SB; El Kabany MM; Choi G; Shetty A; Singh J; Wray C; Barjaktarvic I; Farmer DG; Busuttil RW
    Ann Surg; 2023 Sep; 278(3):441-451. PubMed ID: 37389564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Vs Late Liver Retransplantation: Different Characteristics and Prognostic Factors.
    Moon HH; Kim TS; Song S; Shin M; Chung YJ; Lee S; Choi GS; Kim JM; Kwon CHD; Lee SK; Joh J
    Transplant Proc; 2018 Nov; 50(9):2668-2674. PubMed ID: 30401374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
    Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience.
    Kamei H; Al-Basheer M; Shum J; Bloch M; Wall W; Quan D
    J Surg Res; 2013 Dec; 185(2):877-82. PubMed ID: 23953787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
    Biggins SW; Gralla J; Dodge JL; Bambha KM; Tong S; Barón AE; Inadomi J; Terrault N; Rosen HR
    Am J Transplant; 2014 Nov; 14(11):2588-94. PubMed ID: 25243648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation.
    Brüggenwirth IMA; Werner MJM; Adam R; Polak WG; Karam V; Heneghan MA; Mehrabi A; Klempnauer JL; Paul A; Mirza DF; Pratschke J; Salizzoni M; Cherqui D; Allison M; Soubrane O; Staffa SJ; Zurakowski D; Porte RJ; de Meijer VE;
    Transpl Int; 2021 Oct; 34(10):1928-1937. PubMed ID: 34160850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern Outcomes After Liver Retransplantation: A Single-center Experience.
    Connor AA; Saharia A; Mobley CM; Hobeika MJ; Victor DW; Kodali S; Brombosz EW; Graviss EA; Nguyen DT; Moore LW; Gaber AO; Ghobrial RM
    Transplantation; 2023 Jul; 107(7):1513-1523. PubMed ID: 36706077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center.
    Hong JC; Kaldas FM; Kositamongkol P; Petrowsky H; Farmer DG; Markovic D; Hiatt JR; Busuttil RW
    Ann Surg; 2011 Sep; 254(3):444-8; discussion 448-9. PubMed ID: 21817890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver retransplantation in children. A 21-year single-center experience.
    Bourdeaux C; Brunati A; Janssen M; de Magnée C; Otte JB; Sokal E; Reding R
    Transpl Int; 2009 Apr; 22(4):416-22. PubMed ID: 19040484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors?
    Marti J; Fuster J; Navasa M; Ferrer J; Rimola A; Pelegrina A; Fondevila C; Garcia-Valdecasas JC
    World J Surg; 2012 Dec; 36(12):2914-22. PubMed ID: 22968536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
    Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
    Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes.
    Bittermann T; Hubbard RA; Lewis JD; Goldberg DS
    Am J Transplant; 2019 Dec; 19(12):3319-3327. PubMed ID: 31243887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Elective Status a Predictor of Poor Survival in Liver Retransplantation?
    Stankiewicz R; Kornasiewicz O; Grąt M; Lewandowski Z; Gorski Z; Krawczyk M
    Transplant Proc; 2017; 49(6):1364-1368. PubMed ID: 28736008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study.
    van Reeven M; van Leeuwen OB; van der Helm D; Darwish Murad S; van den Berg AP; van Hoek B; Alwayn IPJ; Polak WG; Porte RJ
    Transpl Int; 2020 Jun; 33(6):667-674. PubMed ID: 32065433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver retransplantation: Timing is equally important.
    Li L; Zhang Y; Xiao F; Qu W; Zhang H; Zhu Z
    Medicine (Baltimore); 2023 Sep; 102(37):e35165. PubMed ID: 37713841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation.
    Karamlou T; Hirsch J; Welke K; Ohye RG; Bove EL; Devaney EJ; Gajarski RJ
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):161-8. PubMed ID: 20434179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients.
    Wood P; Huang YS; Sanchez L; Kitt E; Abt PL; Bittermann T
    Am J Transplant; 2023 Jun; 23(6):794-804. PubMed ID: 36933831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.